Anne-Gaëlle Goubet

7PUBLICATIONS
160CO-AUTHORS
Tumour immunologyMolecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 11, 2024
Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype.

Noah Enbergs, Elias A Halabi, Anne-Gaëlle Goubet

|Jan 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.

François-Xavier Danlos, Matthieu Texier, Bastien Job

|Aug 05, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva

|Feb 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet

|Jul 07, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Anne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud

|May 12, 2021
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae.

Anne-Gaëlle Goubet, Richard Wheeler, Aurélie Fluckiger

Pageof 2

Frequent Collaborators

5 joint publications

Laurence Zitvogel

4 joint publications

Aurélien Marabelle

3 joint publications

Guido Kroemer

3 joint publications

Fabrice Andre